Results 141 to 150 of about 3,877 (186)
Some of the next articles are maybe not open access.
Journal of Toxicology: Clinical Toxicology, 2004
Dipyrone is a pyrazolone derivative used as an analgesic and antipyretic. Agranulocytosis, dipyrone's most serious and potentially fatal adverse effect, has led to its withdrawal in several countries. However, agranulocytosis is subject to geographical variability, ratio with at risks ranging from 0.8-23.7.
Yedidia Bentur, Omri Cohen
exaly +3 more sources
Dipyrone is a pyrazolone derivative used as an analgesic and antipyretic. Agranulocytosis, dipyrone's most serious and potentially fatal adverse effect, has led to its withdrawal in several countries. However, agranulocytosis is subject to geographical variability, ratio with at risks ranging from 0.8-23.7.
Yedidia Bentur, Omri Cohen
exaly +3 more sources
Veterinary Journal, 2015 The analgesic and antihyperalgesic effects of dipyrone, meloxicam or a dipyrone-meloxicam combination were compared in dogs undergoing elective ovariohysterectomy.
Livia R Teixeira +2 more
exaly +2 more sources
The use of dipyrone (metamizol) as an analgesic in children: What is the evidence? A review
Paediatric Anaesthesia, 2017 Dipyrone has analgesic, spasmolytic, and antipyretic effects and is used to treat pain. Due to a possible risk of agranulocytosis with the use of dipyrone, it has been banned in a number of countries.
Thomas G De Leeuw +2 more
exaly +2 more sources
Palliative Medicine, 2017 BACKGROUND Dipyrone (metamizole) is one of the most widely used non-opioid analgesics for the treatment of cancer pain. AIM Because evidence-based recommendations are not yet available, a systematic review was conducted for the German Guideline ...
Jan Gaertner +2 more
exaly +2 more sources